Preventive effects of rosuvastatin on atrial fibrillation: A meta-analysis of randomized controlled trials

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 3058-3060

  Liu, Tong ^a   Korantzopoulos, Panagiotis ^b   Li, Lijian ^c   Li, Guangping ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; C reactive protein; Inflammation; Meta analysis; Rosuvastatin

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ANTIARRHYTHMIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; INFLAMMATION; LETTER; META ANALYSIS; OXIDATIVE STRESS; PATHOGENESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; INFLAMMATION; META-ANALYSIS; ROSUVASTATIN;

ATRIAL FIBRILLATION; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PYRIMIDINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SULFONAMIDES;

EID: 84883746262     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.11.084     Document Type: Article

References (29)

1. S.J. Nicholls, K. Uno, and Y. Kataoka Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk Expert Rev Cardiovasc Ther 9 2011 1383 1390
2. S.J. Nicholls, C.M. Ballantyne, and P.J. Barter Effect of two intensive statin regimens on progression of coronary disease N Engl J Med 365 2011 2078 2087
3. S.H. Han, W.J. Chung, and W.C. Kang Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: comparative analysis with rosuvastatin alone by intravascular ultrasound Int J Cardiol 158 2012 217 224
4. K.H. Yun, M.H. Jeong, and S.K. Oh The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome Int J Cardiol 137 2009 246 251
5. K.H. Yun, S.K. Oh, S.J. Rhee, N.J. Yoo, N.H. Kim, and J.W. Jeong 12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome Int J Cardiol 146 2011 68 72
6. O. Adam, G. Frost, and F. Custodis Role of Rac1 GTPase activation in atrial fibrillation J Am Coll Cardiol 50 2007 359 367
7. W. Xia, Z. Yin, J. Li, Y. Song, and X. Qu Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion Pacing Clin Electrophysiol 32 2009 1562 1566
8. J. Li, W. Xia, W. Feng, and X. Qu Effects of rosuvastatin on serum asymmetric dimethylarginine levels and atrial structural remodeling in atrial fibrillation dogs Pacing Clin Electrophysiol 35 2012 456 464
9. T. Liu, L. Li, P. Korantzopoulos, E. Liu, and G. Li Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies Int J Cardiol 126 2008 160 170
10. L. Fauchier, B. Pierre, A. de Labriolle, C. Grimard, N. Zannad, and D. Babuty Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials J Am Coll Cardiol 51 2008 828 835
11. D.E. Winchester, X. Wen, L. Xie, and A.A. Bavry Evidence of pre-procedural statin therapy a meta-analysis of randomized trials J Am Coll Cardiol 56 2010 1099 1109
12. K. Rahimi, J. Emberson, and P. McGale Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials BMJ 342 2011 d1250
13. W.T. Fang, H.J. Li, H. Zhang, and S. Jiang The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials Br J Clin Pharmacol 74 5 2012 744 756
14. C.N. Bang, A.M. Greve, J. Abdulla, L. Kober, G.H. Gislason, and K. Wachtell The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis Int J Cardiol 167 3 2013 624 630
15. J.M. Pena, J. MacFadyen, R.J. Glynn, and P.M. Ridker High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial Eur Heart J 33 2012 531 537
16. D. Moher, S. Hopewell, and K.F. Schulz Consort 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials BMJ 340 2010 c869
17. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
18. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
19. J. Bowden, J.F. Tierney, A.J. Copas, and S. Burdett Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics BMC Med Res Methodol 11 2011 41
20. S.G. Kanorskii, V.V. Bodrikova, and S.G. Kanorskaia Influence of perindopril, rosuvastatin, or omega-3 polyunsaturated fatty acids on efficacy of antirecurrence therapy with sotalol in patients with persistent atrial fibrillation Kardiologiia 47 2007 39 44
21. V.A. Mannacio, D. Iorio, V. De Amicis, F. Di Lello, and F. Musumeci Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial J Thorac Cardiovasc Surg 136 2008 1541 1548
22. A.P. Maggioni, G. Fabbri, and D. Lucci Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial Eur Heart J 30 2009 2327 2336
23. L. Koutbi, D. Roy, and M. Talajic Statins and atrial fibrillation in patients with left ventricular dysfunction: insights from the AF-CHF trial Int J Cardiol 165 3 2013 575 577
24. P. Patel, H. Dokainish, P. Tsai, and N. Lakkis Update on the association of inflammation and atrial fibrillation J Cardiovasc Electrophysiol 21 2010 1064 1070
25. P. Korantzopoulos, T.M. Kolettis, D. Galaris, and J.A. Goudevenos The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation Int J Cardiol 115 2007 135 143
26. S. Negi, A.A. Sovari, and S.C. Dudley Jr. Atrial fibrillation: the emerging role of inflammation and oxidative stress Cardiovasc Hematol Disord Drug Targets 10 2010 262 268
27. T. Liu, and G. Li Is atrial fibrillation an inflammatory disease? Med Hypotheses 64 2005 1237 1238
28. T. Liu, G. Li, L. Li, and P. Korantzopoulos Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis J Am Coll Cardiol 49 2007 1642 1648
29. H. Takagi, and T. Umemoto A meta-analysis of randomized head-to-head trials of atorvastatin versus rosuvastatin for reductions in C-reactive protein Int J Cardiol 154 2012 78 81